Novartis AG
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

Abstract:

The invention provides methods of making immune effector cells (e.g., T cells, NK cells) that can be engineered to express a chimeric antigen receptor (CAR), and compositions and reaction mixtures comprising the same.